Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus

Condition:   Asthma
Interventions:   Drug: omalizumab;   Biological: Rhinovirus (strain 16)
Sponsors:   University of Virginia;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting – verified March 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days